Condition
Glucocorticoid Induced Osteoporosis
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
3 treatments under study, led by Alendronate Sodium
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Phase 2 (1)
Phase 3 (1)
Trial Status
Not Yet Recruiting1
Unknown1
Clinical Trials (2)
Showing 2 of 2 trials
NCT05397938Phase 2UnknownPrimary
Efficacy and Safety of JMT103 in the Treatment of Glucocorticoid Induced Osteoporosis
SYF1f667b77b4b8404086a0e66a40ffc1daPhase 3Not Yet Recruiting
Zoledronic acid as prophylaxis against glucocorticoid-induced osteoporosis in lymphoma
Showing all 2 trials
Research Network
Common Treatments
- Alendronate Sodium1
- Jmt1031
- Alendronate Sodium Placebo1
Active Sponsors
- Shanghai JMT-Bio Inc.1
Related Conditions
- Large Bcell Lymphomas Transformations Of Indolent Bcell Lymphomas Mantle Cell Lymphoma Follicular Lymphoma Burkitt Lymphoma And Tcell Lymphomas The 5th Edition Of The World Health Organization Classification Of Haematolymphoid Tumours Lymphoid Neoplasms1